XAnge Investor
XAnge is a BCorp-certified early-stage investment fund managing €700 million, with offices in Paris, Berlin, and Brussels. The fund backs European founders who aim to transform daily life through technology, investing between €500,000 and €10 million from the seed stage onwards.
XAnge’s investment focus spans deeptech, health, fintech, SaaS, and e-commerce, with a portfolio including Lydia, Welcome to the Jungle, Believe, MrSpex, and Ledger. XAnge is the innovation-driven venture capital brand of the Siparex Group.
Invests into
.png)
.png)
Investor Type:
Venture Capital
Founded Date:
2003-01-01
Industry:
Medicine and Biology
Employee Number:
11-50
Funding Status:
private
Number Of Exists:
59
Headquarters:
Paris,Ile-de-France,France,Europe
Investors Number:
280
Number Of Investments Funding Rounds:
278
Phone Number:
+33 1 53 43 05 30
Number Of Investments:
278
City:
Paris
Region:
Ile-de-France
Country:
France